NYSE$XRN

Global Medical REIT Inc · Q2 2013 earnings

Q2 2013 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.33

Previous: -$1.88+82.6%
Net Income

-$6.53K

Previous: -$25.8K+74.7%
Operating Income

-$6.53K

Previous: -$25.8K+74.7%
Gross Profit

$0.00

Previous: $0.00
R&D Expense

$0.00

Previous: $0.00

Revenue & EPS history

Global Medical REIT · Revenue · Quarterly

$38M

Q2 2025+10.9%vs Q2 2024

Revenue by segment

Global Medical REIT · $38M total across 2 segments · Q2 2025

  • Rental Revenue
    $37.9M—
  • Other Income
    $89K—

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

+0.2%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+1.1%

Avg return

30 days after

56%

22 / 39 earnings

Positive

+7.3%

Q4 2016

Best reaction

-9.8%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025———
Q1 2026-9.2%-4.2%—
Q4 2025-1.6%-2.6%-13.2%
Q3 2025+1.8%+3.2%+1.7%
Q1 2025-9.8%-11.7%-17.0%
Q4 2024+3.8%+4.4%+3.1%
Q3 2024-2.6%-3.6%-7.4%
Q2 2024-1.8%-0.3%+1.0%
Q1 2024+3.4%+4.8%+8.4%
Q4 2023-5.6%-2.7%-5.7%
Q3 2023-1.8%-0.8%+11.7%
Q2 2023+3.5%+4.8%-1.5%
Q1 2023+0.8%+1.8%+1.9%
Q4 2022-4.0%-1.2%-13.0%
Q3 2022-0.9%+0.2%+12.3%
Q2 2022-0.5%-1.3%-11.0%
Q1 2022-5.3%-11.9%-12.5%
Q4 2021-3.2%-2.2%+1.9%
Q3 2021+1.6%+1.0%-2.5%
Q2 2021-0.7%-0.2%+3.7%
Q1 2021-1.2%+1.0%+5.2%
Q4 2020+1.6%+3.9%+0.2%
Q3 2020+2.0%+1.4%+7.2%
Q2 2020+4.8%+11.4%+11.6%
Q1 2020+7.0%+9.3%+26.0%
Q4 2019+4.7%-7.2%-41.1%
Q3 2019+2.3%+9.5%+22.4%
Q2 2019-0.7%+1.8%+5.0%
Q1 2019+1.4%+4.5%+7.1%
Q4 2018+0.8%+2.6%-2.0%
Q3 2018+2.2%+2.0%+6.4%
Q2 2018+4.3%+6.7%+12.2%
Q1 2018+2.6%-0.1%+4.6%
Q4 2017+5.8%+6.3%+3.9%
Q3 2017+3.1%+3.7%-2.8%
Q2 2017+0.7%+2.8%+2.8%
Q1 2017-1.2%+0.0%+0.3%
Q4 2016+7.3%+9.3%+17.1%
Q3 2016-8.5%-14.9%-0.2%
Q2 2016+1.1%+2.3%-5.0%
Q1 2016———
Q4 2015———
Q3 2015———
Q2 2015———
Q1 2015———
Q4 2014———
Q3 2014———
Q2 2014———
Q1 2014———
Q4 2013———
Q3 2013———
Q2 2013———
Q1 2013———
Q4 2012———
Q3 2012———
Q2 2012———
Q1 2011———
Q4 2011———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro